Document Detail

MicroRNAs: promising therapeutic targets for the treatment of pulmonary arterial hypertension.
MedLine Citation:
PMID:  23379818     Owner:  NLM     Status:  MEDLINE    
INTRODUCTION: MicroRNAs (miRNAs) are small noncoding RNAs that not only regulate gene expression during normal development but can also be active players in several diseases. To date, several studies have demonstrated a possible role for specific miRNAs in the regulation of pulmonary vascular homeostasis suggesting that novel therapeutic agents which target these modulators of gene expression could serve to treat pulmonary arterial hypertension (PAH).
AREAS COVERED: The characterization of miRNA-mediated gene modulation in the pulmonary circulation is expanding very rapidly. This review summarizes current relevant findings on the role of miRNAs in the pathogenesis of PAH and expands on the potential use of agents that target these molecules as future disease-modifying therapies.
EXPERT OPINION: Further understanding of miRNA biology and function in the pulmonary circulation will serve to further enhance our understanding of their contribution to the pathogenesis of PAH. The implementation of a systems biology approach will help accelerate the discovery of miRNAs that influence angiogenesis and cellular responses to vascular injury. Experimental characterization of these miRNAs using in vitro and in vivo methods will be required to validate the biological roles of these miRNAs prior to the consideration of their use as therapeutic targets in future clinical trials.
Ke Yuan; Mark Orcholski; Xuefei Tian; Xiaobo Liao; Vinicio A de Jesus Perez
Related Documents :
24717578 - Role of epigenetics in pulmonary hypertension.
22455098 - Unusual abnormal pulmonary venous return.
23643478 - Nonaneurysmal subarachnoid hemorrhage after udenafil intake.
12797318 - Combined systemic and intrapleural treatment of aspergillus pulmonary empyema after inv...
2898298 - Disappearance of high-grade left anterior descending stenosis after revascularization.
20189408 - Combined distal aortic perfusion and balloon occlusion to facilitate the repair of comp...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review     Date:  2013-02-02
Journal Detail:
Title:  Expert opinion on therapeutic targets     Volume:  17     ISSN:  1744-7631     ISO Abbreviation:  Expert Opin. Ther. Targets     Publication Date:  2013 May 
Date Detail:
Created Date:  2013-04-17     Completed Date:  2013-10-17     Revised Date:  2013-11-06    
Medline Journal Info:
Nlm Unique ID:  101127833     Medline TA:  Expert Opin Ther Targets     Country:  England    
Other Details:
Languages:  eng     Pagination:  557-64     Citation Subset:  IM    
Stanford University, Department of Medicine, Stanford, CA 94305 , USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Hypertension, Pulmonary / genetics*,  therapy
MicroRNAs / genetics*
Reg. No./Substance:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Optimizing Protein Coordination to Quantum Dots with Designer Peptidyl Linkers.
Next Document:  Competing interests declared: early interventions and long-term psychological outcomes.